Clinicopathologic study of triple-negative breast cancer with special reference to basal-like breast cancer phenotype in a tertiary care hospital of Eastern India
DOI:
https://doi.org/10.3126/ajms.v14i9.55167Keywords:
Basal-like breast cancer; Cytokeratin 5/6; Ki-67 proliferation index; Triple negativeAbstract
Background: Triple-negative breast cancer (TNBC) is defined as absent expression of estrogen receptor (ER) and progesterone receptors and human epidermal growth factor receptors (HER2neu). These cancers are associated with poor prognosis.
Aims and Objectives: We aimed at to study the clinicopathological profile and survival among women with TNBC.
Materials and Methods: The study was conducted over a period of 4 years. Surgical specimens of patients with breast cancer were analyzed histopathologically as well as immunohistochemical analysis for estrogen, progesterone, HER2neu, and Ki-67 index was also done. Statistical analysis was done using software version 20.0. Results were expressed in number and percentage. Comparison was done by x2 test. P=0.05 was considered statistically significant.
Results: In our study, 26.92% cases were of TNBC. Predominant age group affected was between 50 and 70 years. Most common histologic type was invasive carcinoma of no special type with higher grade (Grades 2 and 3) mostly with frequent nodal metastasis. Higher percentage of Ki-67 proliferation index and basal cytokeratin expression were associated with higher tumor grade and stage along with reduced short-term disease-free survival on follow-up.
Conclusion: TNBCs are usually of higher grade with frequent recurrences and distant metastasis. There are no widely accepted prognostic markers available. Panel of immunohistochemical markers should be used specially to categorize the basal-like breast cancer subtype among TNBCs for better clinical outcome.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Asian Journal of Medical Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The journal holds copyright and publishes the work under a Creative Commons CC-BY-NC license that permits use, distribution and reprduction in any medium, provided the original work is properly cited and is not used for commercial purposes. The journal should be recognised as the original publisher of this work.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).